Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

As the limitations of antiretroviral drug therapy, such as toxicity and resistance, become evident, interest in alternative therapeutic approaches for human immunodeficiency virus (HIV) infection is growing. We developed the first gene therapeutic strategy targeting entry of a broad range of HIV typ...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Egelhofer, Marc, Brandenburg, Gunda, Martinius, Holger, Schult-Dietrich, Patricia, Melikyan, Gregory, Kunert, Renate, Baum, Christopher, Choi, Ingrid, Alexandrov, Alexander, von Laer, Dorothee
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2004
Sujets:	Vaccines and Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14694088/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.2.568-575.2004
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!